Michael Rousseau
Board
Abbot Laboratories Animal Health
Brazil
Biography
Mr. Michael T. Rousseau is President - Cardiovascular and Neuromodulation of the Company. From 2016 to 2017 — President and Chief Executive Officer, St. Jude Medical, Inc. (a global medical device manufacturer). And also 2014 to 2015 — Chief Operating Officer, St. Jude Medical, Inc. He was from 2012 to 2014 — Group President, Cardiovascular and Ablation Technologies Division, Implantable Electronic Systems Division and U.S. Division, St. Jude Medical, Inc. He was 2009 to 2012 — Group President, Cardiac Rhythm Management Division, Neuromodulation Division, Atrial Fibrillation Division, Cardiovascular Division and U.S. Division, St. Jude Medical, Inc.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology
